hermes pharma limited
hermes pharma limited Company Information
Company Number
11198191
Next Accounts
Nov 2025
Industry
Manufacture of basic pharmaceutical products
Shareholders
zulfiqar ali khan
sarah khan
View AllGroup Structure
View All
Contact
Registered Address
hermes pharma limited, warlies park house, waltham abbey, essex, EN9 3SL
Website
https://hermespharma.co.ukhermes pharma limited Estimated Valuation
Pomanda estimates the enterprise value of HERMES PHARMA LIMITED at £0 based on a Turnover of £0 and 1.31x industry multiple (adjusted for size and gross margin).
hermes pharma limited Estimated Valuation
Pomanda estimates the enterprise value of HERMES PHARMA LIMITED at £0 based on an EBITDA of £0 and a 5.29x industry multiple (adjusted for size and gross margin).
hermes pharma limited Estimated Valuation
Pomanda estimates the enterprise value of HERMES PHARMA LIMITED at £189 based on Net Assets of £100 and 1.89x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Hermes Pharma Limited Overview
Hermes Pharma Limited is a live company located in waltham abbey, EN9 3SL with a Companies House number of 11198191. It operates in the manufacture of basic pharmaceutical products sector, SIC Code 21100. Founded in February 2018, it's largest shareholder is zulfiqar ali khan with a 55% stake. Hermes Pharma Limited is a young, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Hermes Pharma Limited Health Check
There is insufficient data available to calculate a health check for Hermes Pharma Limited. Company Health Check FAQs
0 Strong
0 Regular
0 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Hermes Pharma Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Hermes Pharma Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- Hermes Pharma Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Hermes Pharma Limited
- - Industry AVG
Employees
There is insufficient data available for this Key Performance Indicator!
- - Hermes Pharma Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Hermes Pharma Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Hermes Pharma Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Hermes Pharma Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Hermes Pharma Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Hermes Pharma Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Hermes Pharma Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Hermes Pharma Limited
- - Industry AVG
HERMES PHARMA LIMITED financials
Hermes Pharma Limited's latest turnover from February 2024 is estimated at 0 and the company has net assets of £100. According to their latest financial statements, we estimate that Hermes Pharma Limited has no employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | |
|---|---|---|---|---|---|---|
| Turnover | 0 | 0 | ||||
| Other Income Or Grants | 0 | 0 | ||||
| Cost Of Sales | 0 | 0 | ||||
| Gross Profit | 0 | 0 | ||||
| Admin Expenses | 0 | 0 | ||||
| Operating Profit | 0 | 0 | ||||
| Interest Payable | 0 | 0 | ||||
| Interest Receivable | 0 | 0 | ||||
| Pre-Tax Profit | 0 | 0 | ||||
| Tax | 0 | 0 | ||||
| Profit After Tax | 0 | 0 | ||||
| Dividends Paid | 0 | 0 | ||||
| Retained Profit | 0 | 0 | ||||
| Employee Costs | 0 | 0 | ||||
| Number Of Employees | ||||||
| EBITDA* | 0 | 0 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | |
|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 100 | 100 | 100 | 100 | 100 | 100 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 100 | 100 | 100 | 100 | 100 | 100 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 0 | 0 | 0 | 0 | 0 | 0 |
| total assets | 100 | 100 | 100 | 100 | 100 | 100 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| net assets | 100 | 100 | 100 | 100 | 100 | 100 |
| total shareholders funds | 100 | 100 | 100 | 100 | 100 | 100 |
| Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Profit | 0 | 0 | ||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | ||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 0 | 0 | 0 | 0 | 0 | 0 |
| Creditors | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | 0 | 0 | ||||
| Investing Activities | ||||||
| capital expenditure | ||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 100 |
| cash flow from investments | ||||||
| Financing Activities | ||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||
| interest | 0 | 0 | ||||
| cash flow from financing | 0 | 0 | ||||
| cash and cash equivalents | ||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 |
hermes pharma limited Credit Report and Business Information
Hermes Pharma Limited Competitor Analysis
Perform a competitor analysis for hermes pharma limited by selecting its closest rivals, whether from the MANUFACTURING sector, other young companies, companies in EN9 area or any other competitors across 12 key performance metrics.
hermes pharma limited Ownership
HERMES PHARMA LIMITED group structure
Hermes Pharma Limited has no subsidiary companies.
Ultimate parent company
HERMES PHARMA LIMITED
11198191
hermes pharma limited directors
Hermes Pharma Limited currently has 2 directors. The longest serving directors include Mr Zulfiqar Khan (Feb 2018) and Mr Abbey Khawaja (Oct 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Zulfiqar Khan | England | 56 years | Feb 2018 | - | Director |
| Mr Abbey Khawaja | England | 72 years | Oct 2020 | - | Director |
P&L
February 2024turnover
0
0%
operating profit
0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
February 2024net assets
100
0%
total assets
100
0%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
hermes pharma limited company details
company number
11198191
Type
Private limited with Share Capital
industry
21100 - Manufacture of basic pharmaceutical products
incorporation date
February 2018
age
6
incorporated
UK
ultimate parent company
accounts
Dormant
last accounts submitted
February 2024
previous names
N/A
accountant
-
auditor
-
address
hermes pharma limited, warlies park house, waltham abbey, essex, EN9 3SL
Bank
-
Legal Advisor
-
hermes pharma limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to hermes pharma limited.
hermes pharma limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for HERMES PHARMA LIMITED. This can take several minutes, an email will notify you when this has completed.
hermes pharma limited Companies House Filings - See Documents
| date | description | view/download |
|---|
